10 PM Current Affairs Quiz #17 September 20, 2019

Explanation: The Kerala High Court on Thursday held that the right to have access to the Internet is part of the fundamental right to education as well as the right to privacy under Article 21 of the Constitution. Justice P.V. Asha made the observation while ordering the Principal of Sree Narayanaguru College, Kozhikode, to re-admit a student who had been expelled from the college hostel for using her mobile phone beyond the restricted hours.
The court observed, “When the Human Rights Council of the United Nations has found that the right of access to Internet is a fundamental freedom and a tool to ensure right to education, a rule or instruction which impairs the said right of the students cannot be permitted to stand in the eye of law.”

Explanation: Astra is an active radar homing beyond-visual-range air-to-air missile (BVRAAM) developed by the De fence Research and Development Organization, India. Astra is designed to be capable of engaging targets at varying range and altitudes allowing for engagement of both short-range targets (up to 20 km) and long-range targets (up to 80 km) using alternative propulsion modes. The Astra is a Beyond Visual Range (BVR) missile capable of being launched from India’s Sukhoi-30 MKI twin-jet air superiority fighter. The Indian Air Force currently operates roughly 200 totals Su-30 MKI, but plans to eventually operate around 270. The Astra is 149 inches in length, making it the most compact missile developed indigenously in India capable of supersonic speeds.

Explanation: Poshan Abhiyaan, the world’s largest nutrition programme, expected to benefit 10 crore people and launched in 2018 by Prime Minister Narendra Modi, aims to reduce stunting, underweight, and low birth weight, each by 2% per year; and anaemia among young children, adolescents and women each by 3% per year until 2022. A special target for stunting is set at 25% by 2022.

Explanation: Mussoorie was host to the ‘Himalayan Conclave’ which began in the hillstation on Sunday to deliberate on issues like conservation of the Himalayan ecology, biodiversity and the cultural heritage. Union Finance Minister Nirmala Sitharaman, Chief Ministers of five states with four representative of other four states in the Himalayan region and a host of other dignitaries attended the oneday conclave. Stating his concern, Uttarakhand Chief Minister Trivendra Singh Rawat spoke at the ‘Conclave of the Himalayan States’. “All the participating states want that ‘green bonus’ should be granted to Himalayan states for the ecological services being provided by them.

Explanation: The Central Drugs Standard Control Organisation(CDSCO) under Directorate General of Health Services,Ministry of Health & Family Welfare,Government of India is the National Regulatory Authority (NRA) of India. Its headquarter is located at FDA Bhawan, Kotla Road, New Delhi 110002 and also has six zonal offices,four sub zonal offices,thirteen Port offices and seven laboratories spread across the country. The Drugs & Cosmetics Act,1940 and rules 1945 have entrusted various responsibilities to central & state regulators for regulation of drugs & cosmetics.It envisages uniform implementation of the provisions of the Act & Rules made there under for ensuring the safety, rights and well being of the patients by regulating the drugs and cosmetics. CDSCO is constantly thriving upon to bring out transparency, accountability and uniformity in its services in order to ensure safety, efficacy and quality of the medical product manufactured, imported and distributed in the country. Under the Drugs and Cosmetics Act, CDSCO is responsible for approval of New Drugs, Conduct of Clinical Trials, laying down the standards for Drugs, control over the quality of imported Drugs in the country and coordination of the activities of State Drug Control Organizations by providing expert advice with a view of bring about the uniformity in the enforcement of the Drugs and Cosmetics Act.
Further CDSCO along with state regulators, is jointly responsible for grant of licenses of certain specialized categories of critical Drugs such as blood and blood products, I. V. Fluids, Vaccine and Sera.